Ovid Therapeutics (OVID) announced the appointment of Stelios Papadopoulos, Ph.D. to its Board of Directors. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on OVID: Ovid Therapeutics upgraded at Oppenheimer as OV329’s promise ‘quite real’ Ovid Therapeutics upgraded to Outperform from Perform at Oppenheimer
